Document is current
Any future updates will be listed below
-
Authors
Laible, Mark https://orcid.org/0000-0002-5548-6402
Hartmann, Kerstin
Gürtler, Claudia
Anzeneder, Tobias
Wirtz, Ralph
Weber, Stephan
Keller, Thomas
Sahin, Ugur
Rees, Martin
Ramaswamy, Annette
- License Information
-
More Information
Article History
Received: 20 December 2018
Accepted: 27 June 2019
First Online: 15 July 2019
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.Informed consent was obtained from all individual participants included in the study. The informed consent documents, especially regarding sample donation and data processing, were reviewed by the Bavarian State Office for Data Protection Supervision Authority and approved by the ethics committee of the Medical Faculty of the Rheinischen Friedrich-Wilhelms-Universität Bonn, Germany (vote number: 255/06). All participants gave written informed consent as per PATH Biobank policy.
: Not applicable.
: ML, KH, CG, US: Salary and stock ownership BioNTech Diagnostics GmbH / BioNTech AG. RW: Renumeration and consultancy/advisory role BioNTech Diagnostics GmbH, Stock ownership Stratifyer Molecular Pathology GmbH. SW, TK: Renumeration for statistical analyses BioNTech Diagnostics GmbH. All other authors declare that they have no conflicts of interest.
